Altshuler Shaham Ltd Increases Stake in Synopsys, Inc. $SNPS

Altshuler Shaham Ltd increased its holdings in Synopsys, Inc. (NASDAQ:SNPSFree Report) by 42,200.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,115 shares of the semiconductor company’s stock after buying an additional 2,110 shares during the quarter. Altshuler Shaham Ltd’s holdings in Synopsys were worth $993,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new position in Synopsys in the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys during the 4th quarter valued at approximately $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys in the 4th quarter valued at $32,000. Kemnay Advisory Services Inc. purchased a new position in Synopsys in the 4th quarter valued at $35,000. Finally, Oakworth Capital Inc. lifted its holdings in Synopsys by 3,700.0% in the 4th quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company’s stock valued at $36,000 after purchasing an additional 74 shares in the last quarter. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $461.74 on Thursday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The stock has a 50 day moving average of $477.08 and a two-hundred day moving average of $461.83. The stock has a market cap of $88.41 billion, a P/E ratio of 106.88, a P/E/G ratio of 2.63 and a beta of 1.22.

Synopsys (NASDAQ:SNPSGet Free Report) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company’s revenue for the quarter was up 41.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, research analysts forecast that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Analyst Ratings Changes

SNPS has been the topic of several analyst reports. Piper Sandler lifted their price target on Synopsys from $430.00 to $450.00 and gave the stock a “neutral” rating in a report on Thursday, May 28th. Stifel Nicolaus raised their price objective on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a research report on Thursday, May 28th. HSBC downgraded Synopsys from a “buy” rating to a “hold” rating and set a $455.00 target price for the company. in a research report on Friday, February 20th. KeyCorp reaffirmed an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Finally, Berenberg Bank set a $633.00 price objective on Synopsys in a research report on Wednesday, May 27th. Nine analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $563.81.

View Our Latest Report on Synopsys

Insider Buying and Selling

In other news, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders own 0.56% of the company’s stock.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.